Offerpad Solutions Inc. (OPAD): Nasdaq/NYSE listing notice — Offerpad receives NYSE non-compliance notice for average stock price below $1.00

Offerpad Solutions Inc.

NYSE notified Offerpad on March 3, 2026; avg closing price <$1.00 over 30 consecutive trading days.
Company has six months to cure; can regain compliance if monthly closing price >=$1.00 and 30-day avg >=$1.00.
Offerpad notified NYSE on March 5, 2026 of intent to cure; considering reverse stock split subject to shareholder approval.
Class A common stock (OPAD) continues trading on NYSE during cure period, conditional on other listing standards.
If cure requires shareholder vote, price condition deemed cured if stock exceeds $1.00 and stays above for 30 trading days.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Offerpad Solutions Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

March 3, 2026, Offerpad Solutions Inc. (the “Company,” “we,” “us” or “our”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s Class A common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s Class A common stock from the NYSE. On March 5, 2026, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE c

View on SEC.gov

Browse all listing & compliance notices →

Offerpad Solutions Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-096469

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.